(Q35854960)

10 August 2017

1 reference

title

Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia (English)

1 reference

10 August 2017

0 references

1 reference

Gaiger A

1

1 reference

10 August 2017

Heintel D

series ordinal

2

1 reference

10 August 2017

Jäger U

series ordinal

3

1 reference

10 August 2017

publication date

1 August 2004

1 reference

European Journal of Clinical Investigation

10 August 2017

published in

1 reference

10 August 2017

volume

34 Suppl 2

1 reference

10 August 2017

page(s)

25-30

1 reference

Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

The use and analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Extracting functional information from microarrays: a challenge for functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

From patterns to pathways: gene expression data analysis comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

A guide to drug discovery: Target selection in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Gene expression profiling of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Emerging information on the use of rituximab in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

NF- kappa B2/p100 induces Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Hematologic malignancies: new developments and future treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Towards an understanding of somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Somatic hypermutation of the AID transgene in B and non-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

ZAP-70 tyrosine kinase is required for LFA-1-dependent T cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2004.01367.X

10.1111/J.0960-135X.2004.01367.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference